SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.172+2.3%Dec 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Abe Bleich who wrote (470)8/2/1997 2:25:00 PM
From: Craig Slotoroff   of 1605
 
It looks like VASO has been having a bumpy ride of late. I have been holding VASO for a while now, and like the rest of you, I am waiting for the results of the clinical study. Unfortunatly I don't have the time to follow the stock market like I used to, but since I am involved in clinical research, I am not to alarmed in the delay with the trial. It happens all the time. Does any one have any info in regards to the inclusion criteria needed to enroll patients into the trial? In regards to early postings regarding the placebo effect, that is to be expected in a medical devices trial such as this. If this study was designed well, there should be a significant differance between the patients that recieved acuatly treatment (theraputic levels) and those that recieved the placebo.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext